Cardiovascular Events Associated With Different Combined Oral Contraceptives
- 1 January 2000
- journal article
- review article
- Published by Springer Science and Business Media LLC in Drug Safety
- Vol. 22 (5), 361-371
- https://doi.org/10.2165/00002018-200022050-00004
Abstract
No abstract availableKeywords
This publication has 80 references indexed in Scilit:
- Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over studyThe Lancet, 1999
- Venous thromboembolism amng new users of different oral contraceptives.The Lancet, 1999
- Stroke and Use of Low-Dose Oral Contraceptives in Young WomenStroke, 1998
- Increased risk of cerebral venous sinus thrombosis with third-generation oral contraceptivesThe Lancet, 1998
- Low‐dose oral contraceptives and 24‐hour ambulatory blood pressureInternational Journal of Gynecology & Obstetrics, 1997
- End of the line for “third-generation-pill” controversy?The Lancet, 1997
- Myocardial infarction in users of low-dose oral contraceptivesObstetrics & Gynecology, 1996
- Risk of idiopathic cardiovascular death and rionfatal venous thromboembolism in women using oral contraceptives with differing progestagen componentsThe Lancet, 1995
- Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study.BMJ, 1993
- PULMONARY EMBOLISMThe Lancet, 1961